Seeking Alpha

Medical device manufacturer Haemonetics (HAE -3.5%) gets hit after its FQ2 misses EPS estimates,...

Medical device manufacturer Haemonetics (HAE -3.5%) gets hit after its FQ2 misses EPS estimates, despite beating on revenue. Profits rose 8% Y/Y, but net income declined 35% due to quality issues with its HS Core Bowl and the recall of its OrthoPAT device.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)